Omnicell Inc (OMCL) Stock Analysis

Omnicell Inc (OMCL) is a publicly traded company in the HEALTHCARE sector. It trades at $41.91, carries a market capitalization of $1.96B, a price-to-earnings ratio of 98.09. This page summarizes the public market data, fundamentals, and frequently asked questions for OMCL, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - HEALTH INFORMATION SERVICES

Exchange: NASDAQ

Key Metrics

Market Sentiment

Omnicell Inc currently has a Bullish sentiment score of 0.28.

About Omnicell Inc

Omnicell, Inc. is a leading provider of advanced medication management automation solutions and adherence tools that serve healthcare systems and pharmacies worldwide. Based in Mountain View, California, the company is dedicated to enhancing patient safety and operational efficiency through its innovative technology platform, which includes medication dispensing systems, robotic pharmacy solutions, and comprehensive analytics. With a robust commitment to improving clinical outcomes and mitiga...

GNG Research Analysis

GNG Research scores Omnicell Inc (OMCL) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for OMCL.

Frequently Asked Questions

Does OMCL pay dividends?

Omnicell Inc (OMCL) does not currently pay a regular dividend.

What is OMCL's P/E ratio?

Omnicell Inc has a price-to-earnings (P/E) ratio of 98.09.

What is OMCL's market cap?

Omnicell Inc (OMCL) has a market capitalization of $1.96B with a current stock price of $41.91.